| 000 | 01386 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250518093845.0 | ||
| 264 | 0 | _c20201225 | |
| 008 | 202012s 0 0 eng d | ||
| 022 | _a1873-2968 | ||
| 024 | 7 |
_a10.1016/j.bcp.2020.113944 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFrix, A N | |
| 245 | 0 | 0 |
_aEffectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma. _h[electronic resource] |
| 260 |
_bBiochemical pharmacology _c09 2020 |
||
| 300 |
_a113944 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Allergic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOmalizumab _xtherapeutic use |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSchleich, F | |
| 700 | 1 | _aPaulus, V | |
| 700 | 1 | _aGuissard, F | |
| 700 | 1 | _aHenket, M | |
| 700 | 1 | _aLouis, R | |
| 773 | 0 |
_tBiochemical pharmacology _gvol. 179 _gp. 113944 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bcp.2020.113944 _zAvailable from publisher's website |
| 999 |
_c30808276 _d30808276 |
||